BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Enguita FJ. New promising circulating RNA biomarkers for early diagnosis of lung adenocarcinoma. Ann Transl Med 2019;7:S130. [PMID: 31576337 DOI: 10.21037/atm.2019.05.70] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Atout S, Shurrab S, Loveridge C. Evaluation of the Suitability of RNAscope as a Technique to Measure Gene Expression in Clinical Diagnostics: A Systematic Review. Mol Diagn Ther 2021. [PMID: 34957535 DOI: 10.1007/s40291-021-00570-2] [Reference Citation Analysis]
2 Kolenda T, Guglas K, Baranowski D, Sobocińska J, Kopczyńska M, Teresiak A, Bliźniak R, Lamperska K. cfRNAs as biomarkers in oncology - still experimental or applied tool for personalized medicine already? Rep Pract Oncol Radiother 2020;25:783-92. [PMID: 32904167 DOI: 10.1016/j.rpor.2020.07.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Hosseinalizadeh H, Mahmoodpour M, Ebrahimi A. Circulating non-coding RNAs as a diagnostic and management biomarker for breast cancer: current insights. Mol Biol Rep 2021. [PMID: 34677714 DOI: 10.1007/s11033-021-06847-3] [Reference Citation Analysis]
4 Huang PS, Liao CJ, Huang YH, Yeh CT, Chen CY, Tang HC, Chang CC, Lin KH. Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer. Cancers (Basel) 2021;13:5361. [PMID: 34771525 DOI: 10.3390/cancers13215361] [Reference Citation Analysis]